3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Myelodysplastic Syndromes
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
26
Hematologic Neoplasms
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Lymphoma, Non-Hodgkin
12
Myeloproliferative Disorders
11
Lymphoma
11
Leukemia, Myelomonocytic, Chronic
11
Graft vs Host Disease
10
Primary Myelofibrosis
9
Leukemia
9
Hodgkin Disease
9
Leukemia, Lymphocytic, Chronic, B-Cell
7
Anemia, Refractory, with Excess of Blasts
7
Multiple Myeloma
6
Leukemia, Biphenotypic, Acute
6
Burkitt Lymphoma
5
Polycythemia Vera
4
Lymphoma, Follicular
4
Leukemia, Myeloid
4
Leukemia, Lymphoid
4
Anemia, Aplastic
4
Thrombocythemia, Essential
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precancerous Conditions
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoproliferative Disorders
3
Interventions
rozanolixizumab
8
zilucoplan
7
ravulizumab
6
fludarabine
5
efgartigimod alfa
5
Cyclophosphamide
5
telitacicept
3
Prednisone
3
inebilizumab
2
Rituximab
2
Pyridostigmine Bromide
2
tofacitinib
1
thymoglobulin
1
talquetamab
1
remibrutinib
1
prednylidene
1
iptacopan
1
eculizumab
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Walk Test
1
Therapeutics
1
Tacrolimus
1
Steroids
1
Robotic Surgical Procedures
1
Psychodrama
1
Prednisolone
1
Plasma Exchange
1
Peripheral Blood Stem Cell Transplantation
1
Oxaloacetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myasthenia Gravis
×
Tacrolimus
×
1 year
×
Clear all
NCT04182984
2026-01-30
TREAT-OMG
Tang-Du Hospital
Recruiting
200 enrolled